LOGIN  |  REGISTER
Assertio

Recent Insider Transactions - Enliven Therapeutics (NASDAQ: ELVN)

Follow NASDAQ:ELVN Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ELVN Enliven Therapeutics
Heyman Richard A. / director
10/15/2024
Sell
$27.67
1,270
$35K
124,490
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
10/08/2024
Sell
$27.96
13,167
$368K
1.05M
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
10/08/2024
Sell
$28.51
100
$3K
1.05M
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
10/09/2024
Sell
$28.12
34,289
$964K
1.02M
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
10/09/2024
Sell
$28.52
3,589
$102K
1.02M
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
10/08/2024
Sell
$27.95
13,167
$368K
1.02M
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
10/08/2024
Sell
$28.51
100
$3K
1.02M
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
10/09/2024
Sell
$28.07
13,880
$390K
1.01M
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
10/09/2024
Sell
$28.53
2,830
$81K
1.00M
NASDAQ ELVN Enliven Therapeutics
Ballal Rahul D. / director
10/08/2024
Sell
$19.68
6,314
$124K
69,428
NASDAQ ELVN Enliven Therapeutics
Ballal Rahul D. / director
10/08/2024
Buy
$5.52
4,106
$23K
32,761
NASDAQ ELVN Enliven Therapeutics
Ballal Rahul D. / director
10/08/2024
Buy
$19.68
6,314
$124K
28,655
NASDAQ ELVN Enliven Therapeutics
Ballal Rahul D. / director
10/08/2024
Sell
$28.17
10,420
$294K
22,341
NASDAQ ELVN Enliven Therapeutics
Ballal Rahul D. / director
10/08/2024
Sell
$5.52
4,106
$23K
12,322
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
10/04/2024
Sell
$27.51
7,522
$207K
1.07M
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
10/07/2024
Sell
$27.61
2,707
$75K
1.07M
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
10/04/2024
Sell
$27.51
12,206
$336K
1.04M
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
10/07/2024
Sell
$27.50
2,730
$75K
1.03M
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
10/04/2024
Sell
$2.48
10,218
$25K
182,140
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
10/07/2024
Sell
$2.48
1,270
$3K
180,870
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
10/04/2024
Buy
$2.48
10,218
$25K
10,218
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
10/07/2024
Buy
$2.48
1,270
$3K
2,000
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
10/07/2024
Sell
$27.51
1,270
$35K
0
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
10/04/2024
Sell
$27.51
10,218
$281K
0
NASDAQ ELVN Enliven Therapeutics
Heyman Richard A. / director
10/04/2024
Sell
$27.51
2,825
$78K
125,760
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
10/01/2024
Sell
$27.54
527
$15K
1.08M
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
10/01/2024
Sell
$27.54
526
$14K
1.05M
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
10/01/2024
Sell
$2.48
521
$1K
192,358
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
10/01/2024
Buy
$2.48
521
$1K
521
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
10/01/2024
Sell
$27.54
521
$14K
0
NASDAQ ELVN Enliven Therapeutics
Heyman Richard A. / director
10/01/2024
Sell
$27.54
518
$14K
128,585
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
09/27/2024
Sell
$2.48
4,250
$11K
194,879
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
09/30/2024
Sell
$2.48
2,000
$5K
192,879
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
09/27/2024
Buy
$2.48
4,250
$11K
4,250
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
09/30/2024
Buy
$2.48
2,000
$5K
2,000
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
09/30/2024
Sell
$25.33
2,000
$51K
0
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
09/27/2024
Sell
$24.27
4,250
$103K
0
NASDAQ ELVN Enliven Therapeutics
Heyman Richard A. / director
09/16/2024
Sell
$22.41
1,270
$28K
129,103
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
08/29/2024
Sell
$22.48
11,950
$269K
1.08M
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
08/29/2024
Sell
$23.08
50
$1K
1.08M
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
08/27/2024
Sell
$2.48
4,250
$11K
199,129
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
08/27/2024
Buy
$2.48
4,250
$11K
4,250
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
08/27/2024
Sell
$22.54
4,250
$96K
0
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
08/26/2024
Sell
$22.89
12,000
$275K
1.05M

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous